May 22, 2018 • 8:00 am EDT Corbus Pharmaceuticals Adds Two Key Executives to Lead its Regulatory and CMC Operations
May 15, 2018 • 8:00 am EDT Corbus Pharmaceuticals Announces Acceptance of Three Abstracts for Presentation at EULAR 2018 Annual Meeting
May 10, 2018 • 8:00 am EDT Corbus Pharmaceuticals Reports 2018 First Quarter Financial Results and Provides Business Update
Apr 26, 2018 • 8:00 am EDT Corbus Pharmaceuticals to Present at the Deutsche Bank 43rd Annual Health Care Conference
Mar 12, 2018 • 7:05 am EDT Corbus Pharmaceuticals Reports 2017 Financial Results and Provides Clinical Update
Mar 2, 2018 • 8:00 am EST Corbus Pharmaceuticals to Present at the Cowen & Co. 38th Annual Health Care Conference
Feb 15, 2018 • 7:00 am EST Corbus Pharmaceuticals Announces Publication Demonstrating Lenabasum as First Drug to Stimulate Resolution of Innate Immune Responses in a Clinical Model
Feb 14, 2018 • 7:00 am EST Corbus Pharmaceuticals to Present at the 2018 RBC Capital Markets Global Healthcare Conference
Feb 6, 2018 • 8:00 am EST Corbus Pharmaceuticals to Present at the 7th Annual LEERINK Partners Global Healthcare Conference
Jan 30, 2018 • 7:05 am EST Corbus Pharmaceuticals Receives $25 Million Development Award from the Cystic Fibrosis Foundation to Support Phase 2b Clinical Study of Lenabasum